Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study

doi:10.4254/wjh.v14.i1.260

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3751)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

186

WORD

HTML

1786

Figures (1-2)

341

Tables (1-5)

257

Sum=2643

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

357

Download

751

Sum=1108

Jan 27, 2022 (publication date) through Jul 22, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Jan 27, 2022; 14(1): 260-273
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.260

Table 2 The correlation of clinicopathologic factors and hepatitis B surface antigen expression patterns with viral replication in hepatitis B e antigen positive cases

	HBV DNA		HAI		Fibrosis
Parameters	< 7.67	≥ 7.67	< 9	≥ 9	< 4	≥ 4
n	32	54	48	38	53	33
Age (yr)	48.28 ± 9.6	35.57 ± 8.93^b	37.79 ± 10.83	43.47 ± 10.59^a	36.06 ± 9.39	47.12 ± 10.11^b
Gender
Male	23 (71.9)	25 (46.3)^a	23 (47.9)	25 (65.8)	27 (50.9)	21 (63.6)
Female	9 (28.1)	29 (53.7)	25 (52.1)	13 (34.2)	26 (49.1)	12 (36.4)
HBV DNA (log₁₀IU/mL)	-	-	8.36 ± 2.26	6.79 ± 2.30^a	8.15 ± 2.32	6.89 ± 2.34
HBsAg (log₁₀IU/mL)	3.02 ± 0.91	4.59 ± 0.64^b	4.28 ± 0.91	3.66 ± 1.61^a	4.19 ± 1.01	3.07 ± 1.10^a
ALT IU/L	106.97 ± 73.55	184.74 ± 124.85^a	148.97 ± 61.46	121.46 ± 50.84	167.74 ± 72.1	136.64 ± 56.2
ALT< 200 IU/L	26 (81.2)	26 (48.1)^a	34 (70.8)	18 (47.4)^a	32 (60.4)	20 (60.6)
ALT ≥ 200 IU/L	6 (18.8)	28 (51.9)	14 (29.2)	20 (52.6)	21 (39.6)	13 (39.4)
INR	1.03 ± 0.08	1.05 ± 0.16	1.03 ± 0.10	1.06 ± 0.17	1.04 ± 0.16	1.04 ± 0.09
Platelets (× 10³/μL)	217.59 ± 66.85	233.98 ± 80.60	226 ± 74.74	228 ± 77.51	224.53 ± 74.72	232.61 ± 77.82
HAI score ≥ 9	22 (68.8)	16 (29.6)^b	-	-	17 (32.1)	21 (63.6)^b
HAI score < 9	10 (31.2)	38 (70.4)	-	-	36 (67.9)	12 (36.4)
Fibrosis ≥ 4	19 (59.4)	14 (25.9)^a	12 (25)	21 (55.3)^b	-	-
Fibrosis < 4	13 (40.6)	40 (74.1)	36 (75)	17 (44.7)	-	-
p-HBsAg	29.92 ± 10.84	57.44 ± 25.50^b	53.53 ± 25.12	39.21 ± 22.85^a	54.49 ± 26.02	35.49 ± 18.34^b
HBsAg SP1
A	2 (6.2)	15 (27.8)^a	11 (22.9	6 (15.8)^a	17 (32.1)	0^b
B	4 (12.5)	6 (11.1)	1 (2.1)	9 (23.7)	6 (11.3)	4 (12.1)
C	6 (18.8)	10 (18.5)	12 (25)	4 (10.5)	14 (26.4)	2 (6.1)
D	4 (12.5)	6 (11.1)	7 (14.6)	3 (7.9)	8 (15.1)	2 (6.1)
E	16 (50)	17 (31.5)	17 (35.4)	16 (42.1)	8 (15.1)	25 (75.8)
HBsAg SP2
Diffuse	8 (25)	21 (38.9)	12 (25)	17 (44.7)^a	23 (43.4)	6 (18.2)^b
Globular	8 (25)	16 (29.6)	19 (39.6)	5 (13.1)	22 (41.5)	2 (6.1)
Submembranous	16 (50)	17 (31.5)	17 (35.4)	16 (42.1)	8 (15.1)	25 (75.8)
Membranous expression
Present	5 (15.6)	28 (51.9)^b	21 (43.8)	12 (31.6)	29 (54.7)	4 (12.1)^b
Absent	27 (84.4)	26 (48.1)	27 (56.3)	26 (68.4)	24 (45.3)	29 (87.9)

Data are presented as mean ± SD, number (%).

^aP < 0.05.

^bP < 0.01.

p-HbsAg: Percentage of hepatitis B surface antigen expression; SP: Staining pattern; ALT: Alanine aminotransferase; INR: International normalized ratio; HAI: Histologic activity index; HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus.

Citation: Alpsoy A, Adanir H, Bayramoglu Z, Elpek GO. Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study. World J Hepatol 2022; 14(1): 260-273
URL: https://www.wjgnet.com/1948-5182/full/v14/i1/260.htm
DOI: https://dx.doi.org/10.4254/wjh.v14.i1.260